NCT06587841View on ClinicalTrials.gov

Noninvasive Spinal Cord Stimulation for Early SCI

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
Spinal Cord InjuriesBowel DysfunctionSexual DysfunctionAutonomic DysfunctionUrologic Disorders
Interventions
DEVICE

Spinal COrd NEuromodulation™ (SCONE™) for transcutaneous spinal cord stimulation (TSCS)

The SCONE™ class II investigational device is a non-invasive central nervous system (CNS) stimulator (electrical continence device) designed to provide transcutaneous spinal cord stimulation for the improvement of symptoms of bladder dysfunction associated with centrally-mediated NLUTD.

Trial Locations (1)

V5Z 1M9

RECRUITING

Blusson Spinal Cord Centre, Vancouver

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Rivne Regional War Veterans Hospital, Spinal Cord Injury Rehabilitation Center

UNKNOWN

lead

University of British Columbia

OTHER